OTC Markets OTCPK - Delayed Quote USD

Aoxing Pharmaceutical Company, Inc. (AOXG)

0.0086

-0.0050

(-36.76%)

At close: January 29 at 3:59:37 PM EST

'Tourists' who invaded utilities have gotten a wild ride: Morning Brief

Power companies' stocks have been flying of late, tethered to the AI promise — and its lofty power needs. But this week's shake-up with DeepSeek corrected some of this enthusiasm, taking the sector's new "tourists" for a ride.

Yahoo Finance 2 hours ago

OKLO

VST

CEG
Apple quarterly revenue increases, even as China sales decline 11%

Apple's latest earnings were a mixed bag, with slipping iPhone sales countered by rising revenue. Reporting after the bell Thursday, the iPhone maker’s overall revenue in the first quarter of 2025 beat Wall Street expectations, with a 4% bump to $124.3 billion over the same time last year. Apple reported net income of $36.33 billion, up 7.1% from $33.92 billion in the same year-ago period. The increase came even as the company missed iPhone estimates, with an 11.1% sales drop in China knocking r

TechCrunch 12 hours ago

AAPL
Intel has already received $2.2B in federal grants for chip production

Semiconductor giant Intel Corporation has already received $2.2 billion in federal grants from the U.S. Department of Commerce through the U.S. CHIPS and Science Act, the company shared during its Thursday earnings call. Dave Zinsner, Intel's co-interim CEO, executive vice president, and CFO, said the Silicon Valley-based company received the first tranche of $1.1 billion in federal grants at the end of 2024 and an additional $1.1 billion in January 2025. These grants are based on reaching certa

TechCrunch 13 hours ago

INTC
Mag 7 diverging, Fed uncertainty and tariffs: Market Takeaways

While US stocks (^DJI, ^IXIC, ^GSPC) edged higher to close out Thursday's trading session, Magnificent Seven components continue to diverge as the Big Tech giants continue to report earnings. Yahoo Finance senior markets reporter Josh Schafer joins Asking for a Trend to talk about the trends in mega-cap tech earnings and the Federal Reserve's latest interest rate decision, and the uncertainty around tariffs, To watch more expert insights and analysis on the latest market action, check out more Asking for a Trend here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 15 hours ago

^DJI

GOOG

NVDA
Intel tops Q4 2024 estimates as it continues CEO search

Intel (INTC) released its fourth quarter earnings results after Thursday's market close, beating quarterly revenue estimates with a figure of $14.26 billion (against expectations for $13.81 billion) alongside adjusted earnings per share (EPS) of $0.13 (against expectations for $0.12). Market Domination Overtime's Julie Hyman and Josh Lipton, alongside Head of Citizens JMP Mark Lehmann, react to Intel's earnings results and guidance following the departure of CEO Pat Gelsinger in December 2024. Interim Co-CEOs David Zinsner and Michelle Johnston Holthaus have commented that they have no updates for the company's ongoing chief executive search. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 16 hours ago

INTC
S&P 500 Market Cap vs. Equal Weight: What's the difference?

The S&P 500 (^GSPC) offers two distinct versions — the traditional market cap-weighted index and the equal-weighted index (^SPXEW, ^SP500EW) — each serving different analytical purposes. But what's the key difference between these two approaches? Yahoo Finance Markets and Data Editor Jared Blikre examines these market indicators, explaining their unique weighting methods, how individual stock performance impacts each index differently, and why these distinctions matter for investors making informed market decisions. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Angel Smith

Yahoo Finance Video 20 hours ago

GOOG

^SPXEW

TSLA
Exxon Mobil Q4 Earnings: Mixed Results, But CEO Promises 'Profitable Growth Well Into the Future'

Exxon Mobil Corporation (NYSE:XOM) shares are trading higher after the company reported fourth-quarter results. Total revenues and other income stood at $83.4 billion, missing the consensus of $86.6 billion. Net production in the fourth quarter was 4.6 million oil-equivalent barrels per day, an increase of 20,000 oil-equivalent barrels per day from the prior quarter. Related: Oil Price Drop To Cut Exxon Mobil’s Q4 Upstream Earnings By Up To $0.9 Billion: Details Adjusted net profit came in at $7

Benzinga 4 minutes ago

XOM
Exxon Tops Q4 Estimates as Permian and Guyana Production Soar

Exxon's Q4 earnings exceed expectations, fueled by strong production growth in the Permian and Guyana

GuruFocus.com 16 minutes ago

XOM
Colgate-Palmolive sees weaker annual sales on demand slowdown

Toothpaste maker Colgate-Palmolive forecast annual sales below Wall Street expectations after missing quarterly sales estimates on Friday, hurt by weak demand in North America and Latin America for its household products. WHY IT'S IMPORTANT? The company has seen its organic sales growth slow this year due to repeated price hikes which deterred consumer spending on its daily essential products such as toothpaste as well as pet nutrition.

Reuters 16 minutes ago

CL
AbbVie stock rises on solid annual profit guidance, Q4 beat

Investing.com -- AbbVie (NYSE:ABBV) saw its shares jump more than 4% in premarket trading Friday after the company's profit guidance for the fiscal 2025 year exceeded analyst expectations, driven by strong sales in immunology drugs Skyrizi and Rinvoq.

Investing.com 17 minutes ago

ABBV
Walgreens suspends dividend, breaking 90-plus year streak of shareholder payouts

Shares of Walgreens dove early Friday, a day after the drugstore chain said it was suspending its dividend, breaking a streak of quarterly shareholder payouts that stretches back more than 90 years. The drugstore chain said Thursday after markets closed that it made the move to strengthen its balance sheet and improve free cash flow as company leaders try to turn around the struggling business. Walgreens has been dealing with thin prescription reimbursement, rising costs, persistent theft and inflation-sensitive shoppers who are looking for bargains elsewhere.

Associated Press Finance 18 minutes ago

WBA
Exxon, Chevron Succumb to Oil-Refining Slump as Tariffs Loom

(Bloomberg) -- Profits for Exxon Mobil Corp. and Chevron Corp were slammed by slumping fuel margins as the prospect of US tariffs on two major oil suppliers threatens to make the refining business even worse.Most Read from BloombergManhattan’s Morning Commute Time Drops With New Congestion TollHow the 2025 Catholic Jubilee Is Reshaping RomeTrump Paves the Way to Deputize Local Police on ImmigrationHousing Aid Uncertain After Trump’s Spending Freeze MemoTrump's Federal Funding Pause Threatens Sta

Bloomberg 28 minutes ago

XOM
Why Oklo Inc. (OKLO) Soared on Thursday

We recently compiled a list of the 10 Firms Lead Thursday’s Rally on Better Earnings, Bargain-Hunting. In this article, we are going to take a look at where Oklo Inc. (NYSE:OKLO) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major indices closing higher. The Dow Jones Industrial Average […]

Insider Monkey 41 minutes ago

OKLO
Chevron Q4 Earnings: Profits Decline Amid Lower Oil Output, Dividend Hike Offers Silver Lining

Oil giant Chevron Corp (NYSE:CVX) shares are trading lower after the company reported fourth-quarter results. Revenues and other income of $52.23 billion beat the consensus of $46.75 billion. In the fourth quarter, net oil-equivalent production declined slightly to 3,350 MBOED from 3,392 MBOED a year ago quarter. In 2024, worldwide net oil-equivalent production rose 7% year over year to 3,338 MBOED, led by a full year of legacy PDC Energy and strong production in the Permian Basin (+18% Y/Y). Ad

Benzinga 41 minutes ago

CVX
Q3 2025 Deckers Outdoor Corp Earnings Call

Q3 2025 Deckers Outdoor Corp Earnings Call

Thomson Reuters StreetEvents 42 minutes ago

DECK
Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller

Vertex Pharmaceuticals won FDA approval for its non-opioid painkiller Journavx. Vertex stock jumped in late trading.

Investor's Business Daily 43 minutes ago

VRTX
Q1 2025 Apple Inc Earnings Call

Q1 2025 Apple Inc Earnings Call

Thomson Reuters StreetEvents 43 minutes ago

AAPL
Q4 2024 Intel Corp Earnings Call

Q4 2024 Intel Corp Earnings Call

Thomson Reuters StreetEvents 43 minutes ago

INTC
Apple's China Struggles Weigh on Q1 Results Despite Services Surge

Apple posts mixed Q1 results, as strong Mac, iPad, and Services revenue offset weak iPhone sales in China

GuruFocus.com 52 minutes ago

AAPL
Why Tempus AI Inc. (TEM) Soared on Thursday

We recently compiled a list of the 10 Firms Lead Thursday’s Rally on Better Earnings, Bargain-Hunting. In this article, we are going to take a look at where Tempus AI Inc. (NASDAQ:TEM) stands against the other stocks. Optimistic sentiment continued to drive Wall Street on Thursday, with all major indices closing higher. The Dow Jones Industrial […]

Insider Monkey 53 minutes ago

TEM

Performance Overview

Return	AOXG	S&P 500
YTD	+22.86%	+2.78%
1-Year	+34.38%	+23.20%
3-Year	+186.67%	+36.99%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Aoxing Pharmaceutical Company, Inc. (AOXG)

Related News

'Tourists' who invaded utilities have gotten a wild ride: Morning Brief

Apple quarterly revenue increases, even as China sales decline 11%

Intel has already received $2.2B in federal grants for chip production

Mag 7 diverging, Fed uncertainty and tariffs: Market Takeaways

Intel tops Q4 2024 estimates as it continues CEO search

S&P 500 Market Cap vs. Equal Weight: What's the difference?

Exxon Mobil Q4 Earnings: Mixed Results, But CEO Promises 'Profitable Growth Well Into the Future'

Exxon Tops Q4 Estimates as Permian and Guyana Production Soar

Colgate-Palmolive sees weaker annual sales on demand slowdown

AbbVie stock rises on solid annual profit guidance, Q4 beat

Walgreens suspends dividend, breaking 90-plus year streak of shareholder payouts

Exxon, Chevron Succumb to Oil-Refining Slump as Tariffs Loom

Why Oklo Inc. (OKLO) Soared on Thursday

Chevron Q4 Earnings: Profits Decline Amid Lower Oil Output, Dividend Hike Offers Silver Lining

Q3 2025 Deckers Outdoor Corp Earnings Call

Vertex Pharmaceuticals Jumps On FDA Approval For Non-Opioid Painkiller

Q1 2025 Apple Inc Earnings Call

Q4 2024 Intel Corp Earnings Call

Apple's China Struggles Weigh on Q1 Results Despite Services Surge

Why Tempus AI Inc. (TEM) Soared on Thursday

Performance Overview